Takara Holdings Inc. (TSE: 2531) reported consolidated full-year results for the fiscal year ended March 31, 2026 (FY3/2026) under Japanese GAAP. Revenue rose 8.7% year-on-year to ¥394,316 million from ¥362,693 million, but profitability slipped across every line: operating profit fell 17.1% to ¥17,076 million, ordinary profit dropped 24.0% to ¥16,861 million, and net profit attributable to owners of the parent declined 27.8% to ¥11,696 million from ¥16,202 million. Basic EPS came in at ¥60.52 versus ¥82.98, ROE eased to 4.6%, and the operating margin compressed to 4.3%. Comprehensive income fell 23.1% to ¥19,976 million. The year was a milestone one for the group, which marked its 100th anniversary.
Top-line growth meets a margin squeeze
The defining tension of the year was strong revenue growth running headlong into a profit decline. Sales advanced nearly 9% as Takara Shuzo's domestic liquor and seasoning business held firm and the large overseas Japanese-food and sake distribution operation continued to expand, but the gains did not flow through to the bottom line. Higher input and operating costs, together with sustained investment in the bioscience business, pressured margins, leaving operating profit down 17.1% and net profit down 27.8% even as the top line set a fresh high above ¥394 billion.
Liquor and overseas Japanese food drive revenue
Group revenue is anchored by Takara Shuzo, the parent of the liquor and seasoning operations — shochu, sake, mirin and other Japanese liquors and seasonings — paired with a substantial overseas business distributing Japanese food and sake to international markets. Firm demand across these liquor and Japanese-food channels was the principal engine behind the 8.7% revenue increase, underscoring the durability of Japanese-food consumption abroad even as cost inflation weighed on reported profit.
Bioscience: continued investment and a bolt-on deal
The bioscience arm, Takara Bio — spanning research reagents, gene therapy and related bioscience — remained in an investment phase that weighed on group profit during the year. Takara Holdings also expanded the business through M&A, acquiring Curio Bioscience, Inc., which was newly consolidated and adds capability in spatial-omics. The combination of ongoing development spending and the integration of the new unit was a key contributor to the year's margin compression, with management framing it as groundwork for future growth in the bioscience segment.
Solid balance sheet and cash generation
Takara Holdings closed the year with total assets of ¥513,801 million and net assets of ¥310,937 million, for an equity ratio of 50.5%; owners' equity stood at ¥259,339 million and book value per share at ¥1,344.61. Operating cash flow was ¥17,318 million and period-end cash and equivalents reached ¥69,125 million, giving the group a comfortable financial base to fund both its liquor operations and continued bioscience investment.
¥31 dividend held; FY27 guides a modest recovery
The FY3/2026 annual dividend was set at ¥31.00 per share — a year-end-only payout comprising a ¥29 ordinary dividend plus a ¥2 commemorative dividend marking the company's 100th anniversary — unchanged from the prior year's ¥31.00, for a payout ratio of 50.2%. Management guides a further ¥31.00 annual dividend for FY3/2027. For the coming year, the company guides revenue of ¥420,000 million (+6.5%), operating profit of ¥18,800 million (+10.1%), ordinary profit of ¥17,000 million (+0.8%), and net profit attributable to owners of ¥11,900 million (+1.7%), with EPS of ¥61.70 — a modest profit recovery after the FY3/2026 step-down, driven by expected gains in the core liquor business.
| Metric | FY3/2026 | FY3/2025 | YoY |
|---|---|---|---|
| Revenue (¥M) | 394,316 | 362,693 | +8.7% |
| Operating profit (¥M) | 17,076 | 20,597 | -17.1% |
| Ordinary profit (¥M) | 16,861 | 22,180 | -24.0% |
| Net profit attrib. to owners (¥M) | 11,696 | 16,202 | -27.8% |
| Basic EPS (¥) | 60.52 | 82.98 | -27.1% |
| Annual dividend (¥) | 31.00 | 31.00 | 0.0% |
| FY27 revenue guidance (¥M) | 420,000 | — | +6.5% |
JapanStockPulse provides informational content only and does not constitute investment advice. Figures are taken from the company's published earnings short report and may be subject to subsequent revision.